243
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Association of UCP2-866 G/A Genotype with Autoimmune Hypothyroidism in the Southwestern Saudi Arabia Population

ORCID Icon, , ORCID Icon, , &
Pages 875-879 | Received 22 Dec 2022, Accepted 24 Feb 2023, Published online: 06 Mar 2023

References

  • Mooij P, Drexhage HA. Autoimmune thyroid disease. Clin Lab Med. 1993;13(3):683–697. doi:10.1016/S0272-2712(18)30433-5
  • McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252–265. doi:10.1007/s12020-012-9703-2
  • Merrill SJ, Mu Y. Thyroid autoimmunity as a window to autoimmunity: an explanation for sex differences in the prevalence of thyroid autoimmunity. J Theor Biol. 2015;375:95–100. doi:10.1016/j.jtbi.2014.12.015
  • Tomer Y. Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid. 2010;20(7):715–725. doi:10.1089/thy.2010.1644
  • Kheiroddin P, Rasihashemi SZ, Estiar MA, et al. RET gene analysis in patients with medullary thyroid carcinoma. Clin Lab. 2016;62(5):871–876. doi:10.7754/clin.lab.2015.150907
  • Kilic I, Guldiken S, Sipahi T, et al. Investigation of VEGF and IL-8 gene polymorphisms in patients with differentiated thyroid cancer. Clin Lab. 2016;62(12):2319–2325. doi:10.7754/Clin.Lab.2016.160403
  • Hagen T, Vidal-Puig A. Mitochondrial uncoupling proteins in human physiology and disease. Minerva Med. 2002;93(1):41–57.
  • Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol. 2001;280(4):C719–C741. doi:10.1152/ajpcell.2001.280.4.C719
  • Mattiasson G, Sullivan PG. The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid Redox Signal. 2006;8(1–2):1–38. doi:10.1089/ars.2006.8.1
  • Beitelshees AL, Finck BN, Leone TC, et al. Interaction between the UCP2-866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes. Pharmacogenet Genomics. 2010;20(4):231–238. doi:10.1097/FPC.0b013e3283377abc
  • Díaz-Maroto Cicuéndez I, Fernández-Díaz E, García-García J, et al. The UCP2-866G/A polymorphism could be considered as a genetic marker of different functional prognosis in ischemic stroke after recanalization. Neuromolecular Med. 2017;19(4):571–578. doi:10.1007/s12017-017-8470-x
  • Yang M, Huang Q, Wu J, et al. Effects of UCP2-866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes. Br J Clin Pharmacol. 2009;68(1):14–22. doi:10.1111/j.1365-2125.2009.03431.x
  • Yu X, Wieczorek S, Franke A, et al. Association of UCP2 −866 G/A polymorphism with chronic inflammatory diseases. Genes Immun. 2009;10(6):601–605. doi:10.1038/gene.2009.29
  • Sesti G, Cardellini M, Marini MA, et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes. 2003;52(5):1280–1283. doi:10.2337/diabetes.52.5.1280
  • Chiovato L, Magri F, Carlé A. Hypothyroidism in context: where we’ve been and where we’re going. Adv Ther. 2019;36(Suppl 2):47–58. doi:10.1007/s12325-019-01080-8
  • Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev. 2003;24(5):694–717. doi:10.1210/er.2002-0030
  • Jabrocka-Hybel A, Skalniak A, Piątkowski J, Pach D, Hubalewska-Dydejczyk A. How far are we from understanding the genetic basis of Hashimoto’s thyroiditis? Int Rev Immunol. 2013;32(3):337–354. doi:10.3109/08830185.2012.755175
  • Hong J, Park E, Lee J, Lee Y, Rooney BV, Park Y. Exercise training mitigates ER stress and UCP2 deficiency-associated coronary vascular dysfunction in atherosclerosis. Sci Rep. 2021;11(1):15449. doi:10.1038/s41598-021-94944-5
  • Tian XY, Ma S, Tse G, Wong WT, Huang Y. Uncoupling protein 2 in cardiovascular health and disease. Front Physiol. 2018;9:1060. doi:10.3389/fphys.2018.01060
  • Urbano F, Filippello A, Di Pino A, et al. Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. Am J Physiol Cell Physiol. 2016;310(7):C558–67. doi:10.1152/ajpcell.00148.2015
  • Zhang CY, Baffy G, Perret P, et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell. 2001;105(6):745–755. doi:10.1016/s0092-8674(01)00378-6
  • Stanzione R, Cotugno M, Forte M, et al. Role of uncoupling protein 2 gene polymorphisms on the risk of ischemic stroke in a Sardinian population. Life. 2022;12(5):721. doi:10.3390/life12050721
  • Kaabi YA, Mansor AS, Alfagih AS, et al. Frequency of UCP2 45-bp Ins/Del polymorphism in Saudi population from Jazan area and its association with autoimmune hypothyroidism UCP2 45-bp Ins/Del frequency in hypothyroidism. Int J Health Sci. 2020;14(4):11–16.
  • Taher MA, Hasseb MT, Abd Elneam AI. Mitochondrial uncoupling carrier protein-2 DNA polymorphism (− 866 G/A) as a risk for polycystic ovary syndrome in Saudi Arabian females. Eur Chem Bull. 2016;5(11):483–486.
  • Hamada T, Kotani K, Fujiwara S, et al. The UCP2-866 A/A genotype is associated with low density lipoprotein particle sizes in the general population. Med Sci Monit. 2008;14(3):Cr107–Cr111.
  • Bulotta A, Ludovico O, Coco A, et al. The common −866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in caucasians from Italy. J Clin Endocrinol Metab. 2005;90(2):1176–1180. doi:10.1210/jc.2004-1072